Mobile monitoring company InfoBionic announced that it has raised an additional $8 million for the advancement and expansion of their new product called the MoMe. This round of investment was led by Safeguard Scientifics who previously made 20% equity stake in the company back in 2014. InfoBionic has been successful in raising funds now told to be near $25mm. .
InfoBionic is introducing the MoMe Kardia system used to detect cardiac arrhythmias through analysis of ECG, motion & respiration. The MoMe system automatically transmits the acquired health data to a cloud in real time the information is analyzed by the InfoBionic laboratory. The MoMe device is a multi function monitor that can be used for Holter monitoring, event monitoring and mobile cardiac telemetry. All reports can be accessed by physicians via and iPad application or through the internet.
The MoMe device obtained CE Certification back in 2014 and FDA market clearance for specific clinical applications.